Public Health Ethics 5 (1):22-28 (2012)
The objective of the article is to examine the extensions of a clinical measure of efficacy, the Number Needed to Treat (NNT), in different settings including screening, scanning, genetic testing and primary prevention, and the associated ethical implications. We examine several situations in which the use of the NNT or NNS (Number Needed to Screen) has been suggested, such as Prostate-Specific Antigen for prostate cancer, Magnetic Resonance Imaging scans, genetic testing and banning of smoking. For each application, we explore the ethical implications of the relevant measure. We have found that the different measures have different ethical implications. For example, the Number Needed to Prevent is the only measure that can be lower than one, indicating with a numerical example that prevention is better than cure. Conversely, we raise questions about the acceptability of genetic screening. In a realistic example, we show that primary prevention of the effects of arsenic in drinking water, targeted to the most susceptible, would require to genetically screen a large number of subjects, whereas giving rise to ethical concerns. We warn against the abuse of testing, in particular genetic testing, we show that different measures are associated with different ethical issues and that prevention tends to be better than cure
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
No references found.
Citations of this work BETA
Pharmaceutical Companies and Access to Medicines – Social Integration and Ethical CSR Resolution of a Global Public Choice Problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Similar books and articles
Articles: Validation of Ethical Decision Making Measures: Evidence for a New Set of Measures.Michael D. Mumford, Lynn D. Devenport, Ryan P. Brown, Shane Connelly, Stephen T. Murphy, Jason H. Hill & Alison L. Antes - 2006 - Ethics and Behavior 16 (4):319 – 345.
Polymorphism-Screening: Genetic Testing for Predisposition—Guidance for Technology Assessment. [REVIEW]Claudia Wild - 2008 - Poiesis and Praxis 5 (1):1-14.
Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer.Frances M. Alexakos - 2003 - Dissertation, Salve Regina University
The Ethical Challenges of Direct-to-Consumer Genetic Testing.Cheryl Berg & Kelly Fryer-Edwards - 2007 - Journal of Business Ethics 77 (1):17 - 31.
Predictive Genetic Testing for Conditions That Present in Childhood.Lainie Friedman Ross - 2002 - Kennedy Institute of Ethics Journal 12 (3):225-244.
Ethics of Mandatory Premarital Hiv Testing in Africa: The Case of Goma, Democratic Republic of Congo.Stuart Rennie & Bavon Mupenda - 2008 - Developing World Bioethics 8 (2):126-137.
Screening for Depression in Medical Research: Ethical Challenges and Recommendations. [REVIEW]Aisling M. Sheehan & Hannah McGee - 2013 - BMC Medical Ethics 14 (1):4-.
Exposure to Unethical Career Events: Effects on Decision Making, Climate, and Socialization.Lynn D. Devenport, Ryan P. Brown, Stephen T. Murphy, Alison L. Antes, Ethan P. Waples, Michael D. Mumford & Shane Connelly - 2009 - Ethics and Behavior 19 (5):351-378.
A New Era in Prenatal Testing: Are We Prepared? [REVIEW]Dagmar Schmitz - 2013 - Medicine, Health Care and Philosophy 16 (3):357-364.
Prevention Ethics: Explicating the Context of Prevention Activities.Edison J. Trickett - 1992 - Ethics and Behavior 2 (2):91 – 100.
Added to index2012-03-23
Total downloads52 ( #101,115 of 2,172,658 )
Recent downloads (6 months)9 ( #33,405 of 2,172,658 )
How can I increase my downloads?